The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Proof-of-concept study evaluating a new tool for standardizing radiological assessment of tumor response to treatment in routine clinical practice.
 
Charles Mastier
Consulting or Advisory Role - Deeplink Medical
Travel, Accommodations, Expenses - Deeplink Medical
 
Christelle De La Fouchardiere
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Lilly; Roche; SERVIER; Shire
Research Funding - Roche
Travel, Accommodations, Expenses - Amgen; Amgen; Bristol-Myers Squibb; Celgene; Roche; SERVIER
 
Pierre-Etienne Heudel
No Relationships to Disclose
 
Jerome Fayette
Honoraria - AstraZeneca; Biogen; Bristol-Myers Squibb; Innate Pharma; Merck Serono; Merck Sharp & Dohme
Consulting or Advisory Role - AstraZeneca; BIOGEN; Bristol-Myers Squibb; Innate Pharma; Merck Serono; Merck Sharp & Dohme
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme
 
Matthieu Sarabi
No Relationships to Disclose
 
Nathan Banaste
No Relationships to Disclose
 
Marion Barma
No Relationships to Disclose
 
Elodie mercier-Bischoff
No Relationships to Disclose
 
Medhi Brahmi
No Relationships to Disclose
 
Philippe Alexandre Cassier
Honoraria - Amgen; Blueprint Medicines; Novartis; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Innate Pharma (Inst); Janssen (Inst); Lilly (Inst); Loxo (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Plexxikon (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst); Toray Industries (Inst); Transgene (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Merck Sharp & Dohme; Novartis; Roche
 
Gwenaelle Garin
No Relationships to Disclose
 
David Pérol
Honoraria - AstraZeneca (I); Lilly (I); Roche (I)
Travel, Accommodations, Expenses - AstraZeneca (I); Lilly (I); Roche (I)
 
Frank Pilleul
No Relationships to Disclose
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - Bayer; GlaxoSmithKline; Lilly; Novartis; Pharmamar; Roche
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Merck; Novartis; PharmaMar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Other Relationship - Innate Pharma